Moderate COVID-19: Clinical Trajectories and Predictors of Progression and Outcomes.

Apostolos G PappasAndreas PanagopoulosArtemis RodopoulouMichaella AlexandrouAnna-Louiza ChaliasouKonstantinos SkianisEleftheria KranidiotiEleftheria ChainiIlias C PapanikolaouIoannis Kalomenidis

Published in: Journal of personalized medicine (2022)

, higher systolic blood pressure and lymphopenia are associated with dismal outcomes in patients presenting with moderate COVID-19.

Keyphrases

blood pressure
coronavirus disease
sars cov
high intensity
heart failure
left ventricular
depressive symptoms
hypertensive patients
type diabetes
metabolic syndrome
atrial fibrillation
skeletal muscle
weight loss